Annual Operating Profit
$772.54 M
-$115.88 M-13.04%
December 31, 2023
Summary
- As of February 7, 2025, GMAB annual operating income is $772.54 million, with the most recent change of -$115.88 million (-13.04%) on December 31, 2023.
- During the last 3 years, GMAB annual operating profit has fallen by -$194.75 million (-20.13%).
- GMAB annual operating profit is now -20.13% below its all-time high of $967.28 million, reached on December 31, 2020.
Performance
GMAB Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$312.28 M
+$50.15 M+19.13%
September 1, 2024
Summary
- As of February 7, 2025, GMAB quarterly operating income is $312.28 million, with the most recent change of +$50.15 million (+19.13%) on September 1, 2024.
- Over the past year, GMAB quarterly operating profit has increased by +$66.21 million (+26.91%).
- GMAB quarterly operating profit is now -52.98% below its all-time high of $664.12 million, reached on June 30, 2020.
Performance
GMAB Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$943.79 M
+$66.21 M+7.55%
September 1, 2024
Summary
- As of February 7, 2025, GMAB TTM operating income is $943.79 million, with the most recent change of +$66.21 million (+7.55%) on September 1, 2024.
- Over the past year, GMAB TTM operating profit has increased by +$69.04 million (+7.89%).
- GMAB TTM operating profit is now -16.62% below its all-time high of $1.13 billion, reached on September 30, 2020.
Performance
GMAB TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
GMAB Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.0% | +26.9% | +7.9% |
| 3 y3 years | -20.1% | +419.3% | +10.5% |
| 5 y5 years | +253.4% | +419.3% | +10.5% |
GMAB Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.0% | +64.4% | -11.8% | +419.3% | at high | +104.9% |
| 5 y | 5-year | -20.1% | +95.3% | -53.0% | +2879.3% | -16.6% | +141.1% |
| alltime | all time | -20.1% | +643.1% | -53.0% | +1067.9% | -16.6% | +919.8% |
Genmab A/S Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $312.28 M(+19.1%) | $943.79 M(+7.5%) |
| Jun 2024 | - | $262.13 M(+124.7%) | $877.58 M(+5.7%) |
| Mar 2024 | - | $116.67 M(-53.8%) | $830.00 M(+7.3%) |
| Dec 2023 | $772.54 M(-13.0%) | $252.71 M(+2.7%) | $773.47 M(-11.6%) |
| Sep 2023 | - | $246.07 M(+14.7%) | $874.74 M(-1.7%) |
| Jun 2023 | - | $214.55 M(+256.8%) | $890.10 M(+4.2%) |
| Mar 2023 | - | $60.14 M(-83.0%) | $854.07 M(-2.0%) |
| Dec 2022 | $888.42 M(+89.1%) | $353.99 M(+35.4%) | $871.47 M(+37.9%) |
| Sep 2022 | - | $261.42 M(+46.4%) | $631.92 M(+23.5%) |
| Jun 2022 | - | $178.52 M(+130.2%) | $511.60 M(+11.1%) |
| Mar 2022 | - | $77.54 M(-32.2%) | $460.62 M(-1.9%) |
| Dec 2021 | $469.88 M(-51.4%) | $114.44 M(-18.9%) | $469.32 M(-5.6%) |
| Sep 2021 | - | $141.10 M(+10.6%) | $496.97 M(+1.3%) |
| Jun 2021 | - | $127.54 M(+47.9%) | $490.66 M(-52.2%) |
| Mar 2021 | - | $86.24 M(-39.3%) | $1.03 B(+8.0%) |
| Dec 2020 | $967.28 M(+144.5%) | $142.09 M(+5.4%) | $951.47 M(-15.9%) |
| Sep 2020 | - | $134.79 M(-79.7%) | $1.13 B(+7.9%) |
| Jun 2020 | - | $664.12 M(+6235.9%) | $1.05 B(+158.5%) |
| Mar 2020 | - | $10.48 M(-96.8%) | $405.96 M(+3.7%) |
| Dec 2019 | $395.55 M(+80.9%) | $322.58 M(+516.9%) | $391.52 M(+118.6%) |
| Sep 2019 | - | $52.29 M(+153.7%) | $179.13 M(+13.3%) |
| Jun 2019 | - | $20.61 M(-620.9%) | $158.06 M(-0.6%) |
| Mar 2019 | - | -$3.96 M(-103.6%) | $159.08 M(-26.5%) |
| Dec 2018 | $218.60 M(+6.9%) | $110.19 M(+253.0%) | $216.50 M(-0.5%) |
| Sep 2018 | - | $31.22 M(+44.3%) | $217.58 M(+11.2%) |
| Jun 2018 | - | $21.64 M(-59.5%) | $195.58 M(-22.8%) |
| Mar 2018 | - | $53.46 M(-52.0%) | $253.26 M(+22.7%) |
| Dec 2017 | $204.58 M(+30.7%) | $111.27 M(+1107.7%) | $206.40 M(+4.4%) |
| Sep 2017 | - | $9.21 M(-88.4%) | $197.77 M(-8.7%) |
| Jun 2017 | - | $79.31 M(+1101.8%) | $216.57 M(+36.4%) |
| Mar 2017 | - | $6.60 M(-93.6%) | $158.78 M(+2.7%) |
| Dec 2016 | $156.49 M(+44.0%) | $102.64 M(+266.4%) | $154.60 M(+44.5%) |
| Sep 2016 | - | $28.02 M(+30.2%) | $107.00 M(+6.8%) |
| Jun 2016 | - | $21.52 M(+791.0%) | $100.23 M(+18.6%) |
| Mar 2016 | - | $2.42 M(-95.6%) | $84.54 M(-22.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $108.66 M(+129.7%) | $55.04 M(+159.0%) | $108.32 M(+70.4%) |
| Sep 2015 | - | $21.25 M(+264.1%) | $63.55 M(-5.3%) |
| Jun 2015 | - | $5.84 M(-77.7%) | $67.08 M(+21.0%) |
| Mar 2015 | - | $26.19 M(+155.0%) | $55.41 M(+18.1%) |
| Dec 2014 | $47.30 M(+283.6%) | $10.27 M(-58.5%) | $46.91 M(+1.2%) |
| Sep 2014 | - | $24.77 M(-525.2%) | $46.36 M(+106.8%) |
| Jun 2014 | - | -$5.83 M(-132.9%) | $22.42 M(-10.7%) |
| Mar 2014 | - | $17.69 M(+81.8%) | $25.12 M(+99.6%) |
| Dec 2013 | $12.33 M(-161.2%) | $9.73 M(+1065.0%) | $12.59 M(+748.6%) |
| Sep 2013 | - | $835.10 K(-126.7%) | $1.48 M(-137.8%) |
| Jun 2013 | - | -$3.13 M(-160.8%) | -$3.93 M(-45.8%) |
| Mar 2013 | - | $5.15 M(-475.2%) | -$7.25 M(-64.1%) |
| Dec 2012 | -$20.15 M(-56.8%) | -$1.37 M(-70.0%) | -$20.19 M(-33.7%) |
| Sep 2012 | - | -$4.58 M(-29.1%) | -$30.47 M(-17.4%) |
| Jun 2012 | - | -$6.45 M(-17.1%) | -$36.87 M(-14.3%) |
| Mar 2012 | - | -$7.78 M(-33.2%) | -$43.05 M(-7.6%) |
| Dec 2011 | -$46.59 M(+62.9%) | -$11.65 M(+6.1%) | -$46.59 M(-8.4%) |
| Sep 2011 | - | -$10.98 M(-13.0%) | -$50.84 M(+365.8%) |
| Jun 2011 | - | -$12.63 M(+11.5%) | -$10.91 M(-23.7%) |
| Mar 2011 | - | -$11.33 M(-28.8%) | -$14.31 M(-52.7%) |
| Dec 2010 | -$28.61 M(-69.3%) | -$15.90 M(-154.9%) | -$30.23 M(-27.1%) |
| Sep 2010 | - | $28.94 M(-280.6%) | -$41.48 M(-58.1%) |
| Jun 2010 | - | -$16.03 M(-41.2%) | -$98.89 M(-14.1%) |
| Mar 2010 | - | -$27.24 M(+0.3%) | -$115.13 M(+22.1%) |
| Dec 2009 | -$93.21 M(-34.5%) | -$27.15 M(-4.7%) | -$94.31 M(+40.4%) |
| Sep 2009 | - | -$28.48 M(-11.7%) | -$67.17 M(+73.6%) |
| Jun 2009 | - | -$32.27 M(+402.2%) | -$38.69 M(+502.2%) |
| Mar 2009 | - | -$6.42 M | -$6.42 M |
| Dec 2008 | -$142.23 M(+133.0%) | - | - |
| Dec 2007 | -$61.05 M(-23.2%) | - | - |
| Dec 2006 | -$79.53 M(+11.3%) | - | - |
| Dec 2005 | -$71.47 M(-196.8%) | - | - |
| Dec 2004 | $73.80 M(+41.7%) | - | - |
| Dec 2003 | $52.10 M(-193.0%) | - | - |
| Dec 2002 | -$56.01 M | - | - |
FAQ
- What is Genmab A/S annual operating income?
- What is the all time high annual operating profit for Genmab A/S?
- What is Genmab A/S annual operating profit year-on-year change?
- What is Genmab A/S quarterly operating income?
- What is the all time high quarterly operating profit for Genmab A/S?
- What is Genmab A/S quarterly operating profit year-on-year change?
- What is Genmab A/S TTM operating income?
- What is the all time high TTM operating profit for Genmab A/S?
- What is Genmab A/S TTM operating profit year-on-year change?
What is Genmab A/S annual operating income?
The current annual operating profit of GMAB is $772.54 M
What is the all time high annual operating profit for Genmab A/S?
Genmab A/S all-time high annual operating income is $967.28 M
What is Genmab A/S annual operating profit year-on-year change?
Over the past year, GMAB annual operating income has changed by -$115.88 M (-13.04%)
What is Genmab A/S quarterly operating income?
The current quarterly operating profit of GMAB is $312.28 M
What is the all time high quarterly operating profit for Genmab A/S?
Genmab A/S all-time high quarterly operating income is $664.12 M
What is Genmab A/S quarterly operating profit year-on-year change?
Over the past year, GMAB quarterly operating income has changed by +$66.21 M (+26.91%)
What is Genmab A/S TTM operating income?
The current TTM operating profit of GMAB is $943.79 M
What is the all time high TTM operating profit for Genmab A/S?
Genmab A/S all-time high TTM operating income is $1.13 B
What is Genmab A/S TTM operating profit year-on-year change?
Over the past year, GMAB TTM operating income has changed by +$69.04 M (+7.89%)